ProRx's oral NAD+ is offered in a 1 mL daily-use ampule, compounded under strict USP <795> and cGMP standards in the company's FDA-registered 503B facility. Each batch undergoes third-party potency, ...

ProRx Pharma is moving to disrupt one of the fastest-growing corners of the medical wellness industry with the launch of an ...

Enter generative AI, which the pharma industry is adopting at a terrific rate. By ingesting and analysing vast biological ...

So we were immediately intrigued when she launched her own skincare line, Elm Biosciences, in late 2025 with two products: ...

Antibiotic factories release resistance genes at levels 100x higher than city sewage. Pharmaceutical pollution is fueling ...

Pennsylvania Gov. Shapiro was joined by other state officials in a visit to Eurofins Lancaster Laboratories to announce the expansion, expected to create 250 jobs. Canada making border crossing change ...

With a second late-stage trial win for its investigational HIV combo in the books, Gilead Sciences is moving full steam ahead toward regulatory filings for the novel HIV regimen. In Gilead's ...

Pennsylvania state officials visited Lancaster on Monday to announce a nearly $150 million investment in the Commonwealth's science industry. Gov. Josh Shapiro was joined by Department of Community & ...

Researchers at the University of Geneva (UNIGE) have developed in vitro models of the kidneys, liver and heart for the purposes of testing the effects of new cancer treatments on healthy tissue.

President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S. Watch in our video player above. Pharmaceutical companies Amgen, ...

LOWERING DRUG PRICES FOR AMERICAN PATIENTS: Today, President Donald J. Trump announced nine new agreements with major pharmaceutical companies to lower prescription drug prices for Americans in line ...

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.